Teladoc Health Reports Fourth-Quarter and Full-Year 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
Go back to Teladoc Health Reports Fourth-Quarter and Full-Year 2018 Results
February 28, 2019 9:35 AM EST
Oppenheimer analyst Mohan Naidu lowered the price target on Teladoc (NYSE: TDOC) to $84.00 (from $87.00) while maintaining a Outperform rating.
...
More
February 28, 2019 9:00 AM EST
Cantor Fitzgerald analyst Steven Halper lowered the price target on Teladoc (NYSE: TDOC) to $70.00 (from $83.00) while maintaining a Neutral rating following the company's 4Q earnings report. Revenue was $123M vs. consensus of $120M. Adjusted EBITDA was $5.8M vs. $2.4M a year... More
February 27, 2019 4:05 PM EST
Teladoc (NYSE: TDOC) reported Q4 EPS of ($0.35), $0.01 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $122.74 million versus the consensus estimate of $120 million.
We had an exceptional 2018 with solid performance across all of our key financial and operational metrics, enabling us to enter 2019 with significant momentum. As virtual care becomes mainstream, we are uniquely positioned across all of our channels as the only global comprehensive virtual healthcare solution, said Jason Gorevic, chief executive officer, Teladoc Health. We... More
